|Bid||34.92 x 1400|
|Ask||34.94 x 800|
|Day's Range||34.61 - 36.10|
|52 Week Range||21.79 - 37.35|
|Beta (3Y Monthly)||1.21|
|PE Ratio (TTM)||36.77|
|Earnings Date||Oct 23, 2019|
|Forward Dividend & Yield||0.34 (0.94%)|
|1y Target Est||36.57|
Could LeMaitre Vascular, Inc. (NASDAQ:LMAT) be an attractive dividend share to own for the long haul? Investors are...
BURLINGTON, Mass., Nov. 15, 2019 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at two conferences in November. David Roberts, President,.
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]
Anyone interested in LeMaitre Vascular, Inc. (NASDAQ:LMAT) should probably be aware that the Chairman & CEO, George...
LeMaitre (LMAT) delivered earnings and revenue surprises of 19.05% and 3.56%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
BURLINGTON, Mass., Oct. 23, 2019 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2019 results, provided.
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The acquired patches, marketed under the brands CardioCel® and VascuCel®, are processed in a manner that is intended to reduce the risk of calcification. Annualized 2019 sales of these product lines were $7.1 million, mostly in the US and Europe. Guidance on how this acquisition may affect LeMaitre Vascular’s 2019 revenue, operating income and EPS expectations will be provided at the Company’s Q3 2019 earnings call on October 23, 2019.
BURLINGTON, Mass., Oct. 11, 2019 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2019 financial results on Wednesday, October.
Today we'll evaluate LeMaitre Vascular, Inc. (NASDAQ:LMAT) to determine whether it could have potential as an...
Chairman and CEO of Lemaitre Vascular Inc (30-Year Financial, Insider Trades) George W Lemaitre (insider trades) sold 38,695 shares of LMAT on 09/13/2019 at an average price of $34.86 a share. Continue reading...
George LeMaitre became the CEO of LeMaitre Vascular, Inc. (NASDAQ:LMAT) in 1992. This report will, first, examine the...
LeMaitre Vascular, Inc. (NASDAQ:LMAT) is about to trade ex-dividend in the next 2 days. You can purchase shares before...